HOME >> MEDICINE >> NEWS
Chemotherapy trial proves the worth of including elderly patients in clinical trials

ct for both drugs was haematologic toxicity; this includes symptoms such as a low red blood cell count which can lead to tiredness, a low white blood cell count which can lead to a risk of infection, and a risk of haemorrhages. However no patients in the trial suffered from infection or haemorrhages.

Some women on epirubicin suffered from hair loss and mucositis (which produces symptoms such as soreness in the mouth area so that patients have difficulty swallowing). Low white blood cell counts were found in 18% of women on epirubicin and 20% of women on gemcitabine, but this did not lead to infection.

Dr. Feher said: The results of this large multicentre phase lll study demonstrate the effectiveness and safety of chemotherapy in elderly women with metastatic breast cancer. Epirubicin was more effective than gemcitabine in terms of time to progressive disease and tumour response.

This study shows how important it is to perform clinical trials targeting the elderly, so that we can learn more precisely about the efficacy and tolerability of potential toxic treatments in this population. For instance, the excellent tolerance observed in both arms of our trial was surprising. Oncologists should be encouraged to enrol the elderly in clinical trials.


'"/>

Contact: Emma Mason
wordmason@aol.com
44-0-7711-296-986
Federation of European Cancer Societies
20-Mar-2002


Page: 1 2

Related medicine news :

1. Chemotherapy, but not tamoxifen, associated with stroke risk after breast cancer treatment
2. Chemotherapy plus radiation therapy for head and neck cancer increases survival rates of some patients
3. Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia
4. Women Who Have Invasive Cervical Cancer Benefit From Addition Of Chemotherapy To Radiation Treatment
5. Discovery May Boost Effectiveness Of Chemotherapy
6. Promising New Drug Uses Antibody Targeted Chemotherapy To Fight Leukemia
7. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
8. Better Survival For Women With Breast Cancer -New Evidence On Chemotherapy
9. Lack of clinical trial participation may contribute to lower survival rates
10. Protecting children from industrial chemicals in the environment
11. Hopkins begins human trials with donor adult stem cells to repair muscle damaged from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... ... "Pacifica Experience" Open House day on Pacifica's Lambert Campus, 249 Lambert Road, ... Depth Psychology, the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program ...
(Date:9/12/2019)... Ohio (PRWEB) , ... September 12, 2019 , ... ... on both a local and national scale in two recent and well-renowned listing ... country’s fastest-growing privately held businesses for the 2019 year. , Dr. Jeffrey ...
(Date:9/11/2019)... ... , ... A September 2 article on CBS News details a ... likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a control ... surgery specialists Dr. Feiz and Associates says the study adds further evidence to an ...
(Date:9/11/2019)... (PRWEB) , ... September 11, 2019 , ... ... will exhibit at the 2019 AHIMA Health Data and Information Conference in Chicago, ... stop by booth #505 to learn more about GRM’s healthcare information management ...
(Date:9/11/2019)... ... September 11, 2019 , ... ... challenges facing specialty healthcare, announces the issuance of a patent to reduce the ... payment plan for both time-of-service and post visit patient statements. , At the ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... (PRWEB) , ... September 14, 2019 , ... ... of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County found ... consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J talc ...
(Date:9/12/2019)... CITY (PRWEB) , ... September 12, 2019 , ... ... are collaborating to help make the services of CPESN’s clinically integrated network of ... and payers. CPESN USA’s participating pharmacies provide high quality clinical service programs ...
(Date:9/11/2019)... FALLS CHURCH, Va. (PRWEB) , ... September 11, ... ... explosion is revolutionizing image analysis, with many companies developing technologies to evaluate medical ... segments. , Unless one understands the approaches the FDA is taking to AI-based ...
Breaking Medicine Technology:
Cached News: